Trading Day Review: Acadia Healthcare Company Inc (ACHC) Loses Momentum, Closing at 77.44

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Acadia Healthcare Company Inc (NASDAQ: ACHC) closed at $77.44 in the last session, down -0.64% from day before closing price of $77.94. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 0.51 million shares were traded. ACHC stock price reached its highest trading level at $78.35 during the session, while it also had its lowest trading level at $77.11.

Ratios:

We take a closer look at ACHC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.64.

On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $100.

On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $83.Cantor Fitzgerald initiated its Neutral rating on April 21, 2023, with a $83 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 30 ’24 when Hollinsworth John S. bought 20,000 shares for $53.02 per share.

Hollinsworth John S. bought 10,000 shares of ACHC for $812,065 on Aug 29 ’24. On Aug 08 ’24, another insider, Hollinsworth John S., who serves as the Officer of the company, bought 5,000 shares for $71.57 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 7238069248 and an Enterprise Value of 9200183296. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.35 while its Price-to-Book (P/B) ratio in mrq is 2.40. Its current Enterprise Value per Revenue stands at 3.009 whereas that against EBITDA is 13.687.

Stock Price History:

Over the past 52 weeks, ACHC has reached a high of $87.77, while it has fallen to a 52-week low of $62.04. The 50-Day Moving Average of the stock is 6.40%, while the 200-Day Moving Average is calculated to be 3.66%.

Shares Statistics:

According to the various share statistics, ACHC traded on average about 919.02K shares per day over the past 3-months and 674490 shares per day over the past 10 days. A total of 91.26M shares are outstanding, with a floating share count of 90.07M. Insiders hold about 3.01% of the company’s shares, while institutions hold 104.86% stake in the company. Shares short for ACHC as of 1724976000 were 3859902 with a Short Ratio of 4.20, compared to 1722384000 on 3541022. Therefore, it implies a Short% of Shares Outstanding of 3859902 and a Short% of Float of 4.24.

Earnings Estimates

The company has 11.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.87, with high estimates of $0.92 and low estimates of $0.82.

Analysts are recommending an EPS of between $3.6 and $3.45 for the fiscal current year, implying an average EPS of $3.53. EPS for the following year is $3.97, with 11.0 analysts recommending between $4.26 and $3.82.

Revenue Estimates

According to 11 analysts, the current quarter’s revenue is expected to be $819.87M. It ranges from a high estimate of $833.4M to a low estimate of $809.02M. As of the current estimate, Acadia Healthcare Company Inc’s year-ago sales were $750.33MFor the next quarter, 11 analysts are estimating revenue of $823.52M. There is a high estimate of $836.75M for the next quarter, whereas the lowest estimate is $812.2M.

A total of 11 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.22B, while the lowest revenue estimate was $3.19B, resulting in an average revenue estimate of $3.21B. In the same quarter a year ago, actual revenue was $2.93BBased on 11 analysts’ estimates, the company’s revenue will be $3.53B in the next fiscal year. The high estimate is $3.62B and the low estimate is $3.49B.

Most Popular